NEW YORK (GenomeWeb) – Benchling announced yesterday that it has raised $7 million in a private financing round led by Thrive Capital with participation from existing investor Andreessen Horowitz and angel investors Errik Anderson and Ashton Kutcher.

The digital lab notebook software company said it would use the funding to further invest in its products — which include a design tool for CRISPR guide RNAs and a bioregistry for tracking biological entities — as well as to scale its scientific operations.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.